Regulation of preB cell apoptosis by aryl hydrocarbon receptor/transcription factor-expressing stromal/adherent cells

Proceedings of the Society for Experimental Biology and Medicine

Volumn 221, Issue 3, 1999, Pages 242-252

  Near, Richard I ^b   Matulka, Raymond A ^a   Mann, Koren K ^b   Gogate, Shaila U ^a   Trombino, Anthony F ^b   Sherr, David H ^a,b  

^a BOSTON UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON; POLYCYCLIC AROMATIC HYDROCARBON; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG EFFECT; FLOW CYTOMETRY; GENETIC REGULATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LIVER PARENCHYMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL;

EID: 0033050778     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1373.1999.d01-82.x     Document Type: Article

References (75)

1. Perdew GH. Association of the Ah receptor with the 90-kDa heat shock protein. J Biol Chem 263:13802-13805, 1988.
2. Meyer BK, Pray-Grant MG, Vanden Heuvel JP, Perdew GH. Hepatitis B virus X-associated protein 2 is a subunit of the unliganded aryl hydrocarbon receptor core complex and exhibits transcriptional enhancer activity. Mol Cell Biol 18:978-988, 1998.
3. Bigelow SW, Nebert DW. The Ah regulatory gene product, survey of nineteen polycyclic aromatic compounds' and fifteen benzo[a]pyrene metabolites' capacity to bind to the cytosolic receptor. Toxicol Lett 10:109-118, 1982.
4. Cuthill S, Poellinger L, Gustafsson J-A. The receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in the mouse hepatoma cell line Hepa-1c1c7. J Biol Chem 262:3477-3481, 1987.
5. Dolwick KM, Swanson HI, Bradfield CA. In vitro analysis of Ah receptor domains involved in ligand-activated DNA recognition. Proc Natl Acad Sci USA 90:8566-8570, 1993.
6. Hankinson O. The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol 35:307-340, 1995.
7. Ema M, Sogawa K, Watanabe N, Chujoh Y, Matsushita N, Gotoh O, Funae Y, Fujii-Kuriyama Y. cDNA cloning and structure of mouse putative Ah receptor. Biochem Biophys Res Commun 184:246-253, 1992.
8. Probst MR, Fan CM, Tessier-Lavigne M, Hankinson O. Two murine homologs of the Drosophila single-minded protein that interact with the mouse aryl hydrocarbon receptor nuclear translocator protein. J Biol Chem 272:4451-1457, 1997.
9. Schmidt JV, Su GH-T, Reddy JK, Simon MC, Bradfield CA. Characterization of a murine Ahr null allele: Involvement of the Ah receptor in hepatic growth and development. Proc Natl Acad Sci USA 93:6731-6736, 1996.
10. Carrier F, Chang CY, Duh JL, Nebert DW, Puga A. Interaction of the regulatory domains of the murine CyP1a1 gene with two DNA-binding proteins in addition to the Ah receptor and the Ah receptor nuclear translocator (ARNT). Biochem Pharmacol 48:1767-1778, 1994.
11. Wen LP, Koeiman N, Whitlock JP Jr. Dioxin-inducible, Ah receptor-dependent transcription in vitro. Proc Natl Acad Sci USA 85:8545-8549, 1990.
12. Larsen M, Angus W, Brake P, Eltom S, Jefcoate C. CYP1B1 represents the major PAH-responsive P450 cytochrome constitutively expressed in normal primary HMEC. Fundam Appl Toxicol 36:24-30, 1997.
13. Nebert DW, Gonzalez FJ. P450 genes: Structure, evolution, and regulation. Annu Rev Biochem 56:945-993, 1987.
14. Bombick DW, Jankun J, Tullis K, Matsumura F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes increases in expression of c-erb-A and levels of protein-tyrosine kinases in selected tissues of responsive mouse strains. Proc Natl Acad Sci USA 85:4128-4132, 1988.
15. Puga A, Newbert DW, Carrier F. Dioxin induces expression of c-fos and c-jun proto-oncogenes and a large increase in transcription factor AP-1. DNA Cell Biol 11:269-281, 1992.
16. Sadhu DN, Merchant M, Safe SH, Ramos KS. Modulation of protooncogene expression in rat aortic smooth muscle cells by benzo[a]-pyrene. Arch Biochem Biophys 300:124-131, 1993.
17. Sutter TR, Guzman K, Dold KM, Greenlee WF. Targets for dioxin: Genes for plasminogen activator inhibitor-2 and interleukin-1β. Science 254:415-418, 1991.
18. Gaido KW, Maness SC. Regulation of gene expression and acceleration of differentiation in human keratinocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 127:199-208, 1994.
19. Ma X, Babish JG. Acute 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure results in enhanced tyrosylphosphorylation and expression of murine hepatic cyclin dependent kinases. Biochem Biophys Res Commun 197:1070-1077, 1993.
20. Ma Q, Whitlock JP Jr. The aromatic hydrocarbon receptor modulates the Hepa-1c1c7 cell cycle differentiated state independently of dioxin. Mol Cell Biol 16:2144-2150, 1996.
21. Clark GC, Blank J, Germolec D, Luster MI. 2,3,7,8-Tetrachlorodibenzo-p-dioxin stimulation of tyrosine phosphorylation in B lymphocytes: Potential role in immunosuppression. Mol Pharmacol 39:495-501, 1991.
22. Hardin JA, Hinoshita F, Sherr DH. Mechanisms by which benzo[a]-pyrene, an environmental carcinogen, suppresses B cell lymphopoiesis. Toxicol Appl Pharmacol 117:155-164, 1992.
23. Holsapple MP, Morris DL, Wood SC, Snyder NK. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced changes in immunocompetence: Possible mechanisms. Annu Rev Pharmacol Toxicol 31:73-100, 1991.
24. Kawabata TT, White KL. Suppression of the in vitro humoral immune response of mouse splenocytes by benzo[a]pyrene metabolites and inhibition of benzo[a]pyrene-induced immunosuppression by α-naphthaflavone. Cancer Res 47:2317-2322, 1987.
25. Kerkvliet NI, Steppan LB, Brauner JA, Deyo HA, Henderson MC, Tomar RS, Buhler DR. Influence of the Ah locus on the humoral immunotoxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: Evidence for Ah-receptor-dependent and Ah-receptor-independent mechanisms of immunosuppression. Toxicol Appl Pharmacol 105:26-36, 1990.
26. Ladics GS, Kawabata TT, White KL Jr. Suppression of the in vitro humoral immune response of mouse splenocytes by 7,12-dimethylbenz[a]anthracene metabolites and inhibition of immunosuppression by α-naphthoflavone. Toxicol Appl Pharmacol 110:31-44, 1991.
27. Morris DL, Snyder NK, Gokani V, Blair RE, Holsapple MP. Enhanced suppression of humoral immunity in DBA/2 mice following subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Appl Pharmacol 112:128-132, 1992.
28. Morris DL, Jeong HG, Stevens WD, Chun YJ, Karras JG, Holsapple MP. Serum modulation of the effects of TCDD on the in vitro antibody response and on enzyme induction in primary hepatocytes. Immunopharmacol 27:93-105, 1994.
29. White KL Jr., Lysy HH, Holsapple MP. Immunosuppression by polycyclic aromatic hydrocarbons: A structure-activity relationship in B6C3F1 and DBA/2 mice. Immunopharmacol 9:155-164, 1985.
30. Wojdani A, Attarzadeh M, Wode-Tsadik G, Alfred LJ. Immunocytotoxicity effects of polycyclic aromatic hydrocarbons on mouse lymphocytes. Toxicology 31:181-189, 1984.
31. Burchiel SW, Hadley WM, Barton SL, Fincher RH, Lauder LD, Dean JH. Persistent suppression of humoral immunity produced by 7,12-dimethylbenz[a]anthracene (DMBA) in B6C3F1 mice: Correlation with changes inn spleen cell surface markers detected by flow cytometry. Int J Immunopharmacol 10:369-376, 1988.
32. Thurmond LM, House RV, Lauer LD, Dean JH. Suppression of splenic lymphocyte function by 7,12-dimethylbenz[a]anthracene in murine lymphoid cells. Toxicol Appl Pharmacol 93:369-377, 1988.
33. Ward EC, Murray MJ, Lauder LD, House RV, Dean JH. Persistent suppression of humoral and cells mediated immunity in mice following exposure to the polycyclic aromatic hydrocarbon, 7,12-dimethylbenz[a]anthracene. Int J Immunopharmacol 8:13-22, 1986.
34. Dean JH, Luster MI, Boorman GA, Lauer LD, Luebke RW, Lawson LD. Immune suppression following exposure of mice to the carcinogen benzo[a]pyrene but not the noncarcinogenic benzo[e]pyrene. Clin Exp Immunol 52:199, 1983.
35. Poland A, Knutson JC. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: Examination of the mechanism of toxicity. Annu Rev Pharmacol Toxicol 22:517-554, 1982.
36. Silverstone AE, Frazier DE Jr, Fiore NC, Soults JA, Gasciewicz TA. Dexamethasone, β-estradiol, and 2,3,7,8-tetrachlorodibenzo-p-dioxin elicit thymic atrophy through different cellular targets. Toxicol Appl Pharmacol 126:248, 1994.
37. Blaylock BL, Holliday SD, Comment CE, Heindel JJ, Luster MI. Exposure to tetrachlorodibenzo-p-dioxin (TCDD) alters fetal thymocyte maturation. Toxicol Appl Pharmacol 112:207-213, 1992.
38. Holladay SD, Smith B. Alterations in murine fetal thymus and liver hematopoietic cell populations following developmental exposure to 7,12-dimethylbenz[a]anthracene. Exp Res 68:106-113, 1995.
39. Holladay SD, Smith BJ. Fetal hematopoietic alterations after maternal exposure to benzo[a]pyrene: A cytometric evaluation. J Toxicol Environ Health 42:259-273, 1994.
40. Fine JS, Silverstone AE, Gasiewicz TA. Impairment of prothymocyte activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Immunol 144:1169-1176, 1990.
41. Harper N, Steinberg M, Thomsen J, Safe S. Halogenated aromatic hydrocarbon-induced suppression of the plaque-forming cell response in B6C3F1 splenocytes cultured with allogeneic mouse serum: Ah receptor structure activity relationships. Toxicol 99:199-206, 1995.
42. Yamaguchi K, Matulka RA, Shneider A, Toselli P, Tombino AF, Yang S, Hafer LJ, Mann KK, Tao X-J, Tilly JL, Near R, Sherr DH. Induction of preB cell apoptosis by 7,12 dimethylbenz[a]anthracene in long-term bone marrow cultures. Toxicol Appl Pharmacol 147:190-203, 1997.
43. Yamaguchi K, Near RI, Matulka RA, Shneider A, Toselli P, Trombino AF, Sherr DH. Activation of the aryl hydrocarbon receptor/ transcription factor and bone marrow stromal cell-dependent preB cell apoptosis. J Immunol 158:2165-2173, 1997.
44. Greenlee WF, Dold KM, Irons RD, Osborne R. Evidence for direct action of 2,3,7,8-tetrachorodibenzo-p-dioxin (TCDD) on thymic epithelium. Toxicol Appl Pharmacol 79:112-120, 1985.
45. Kremer J, Gleichmann E, Esser C. Thymic stroma exposed to aryl hydrocarbon receptor-binding xenobiotics fails to support proliferation of early thymocytes but induces differentiation. J Immunol 153:2778-2786, 1994.
46. Whitlock CA, Robertson D, Witte ON. Murine B-cell lymphopoiesis in long-term culture. J Immunol Methods 67:353-369, 1984.
47. Pietrangeli CE, Hayashi S-I, Kincade PW. Stromal cell lines which support lymphocyte growth: Characterization, sensitivity to radiation and responsiveness to growth factors. Eur J Immunol 18:863-872, 1988.
48. Chang C, Smith DR, Prasad VS, Sidman CL, Nebert DW, Puga A. Ten nucleotide differences, five of which cause amino acid changes, are associated with the Ah receptor locus polymorphism of C57BL/6 and DBA/2 mice. Pharmacogenetics 3:312-321, 1993.
49. Miller AG, Israel D, Whitlock JP Jr. Biochemical and genetic analysis of variant mouse hepatoma cell defective in the induction of benzo[a]-pyrene-metabolizing enzyme activity. J Biol Chem 258:3523-3527, 1983.
50. Faas SJ, Rothstein JL, Kreider BL, Rovera G, Knowles BB. Phenotypically diverse mouse thymic stromal cell lines which induce proliferation and differentiation of hemotopoietic cells. Eur J Immunol 23:1201-1214, 1993.
51. Vukmanovic S, Stells G, King PD, Dyall R, Hogquist KA, Harty JT, Nikolic-Zugic J, Bevan MJ. A positive selecting thymic epithelial cell line lacks costimulatory activity. J Immunol 152:3814-3823, 1994.
52. Singh SS, Perdew GW. Alterations in the AhR level after staurosporine treatment. Arch Biochem Biophys 305:170-175, 1993.
53. Burbach KM, Poland A, Bradfield CA. Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc Natl Acad Sci USA 89:8185-8189, 1992.
54. Israel D, Whitlock JP Jr. Induction of mRNA for cytochrome P1-450 in wild type and variant mouse hepatoma lines. J Biol Chem 258:10390-10394, 1983.
55. + B-cell subset. Seminars Immunol 8:37, 1996.
56. Gasiewicz TA, Rucci G. α-Naphthoflavone acts as an antagonist of 2,3,7,8-tetrachlorodibenzo-p-dioxin by forming an inactive complex with the Ah receptor. Mol Pharmacol 40:607-612, 1991.
57. Hoffman EC, Reyes H, Chu F, Sander F, Conley LH, Brooks BA, Hankinson O. Cloning of a factor required for activity of the Ah (Dioxin) receptor. Science 252:954-958, 1991.
58. Hogan B, Beddington R, Constantini F, Lacy E. Manipulating the mouse embryo: A laboratory manual (2nd ed). Plainview, NY: Cold Spring Harbor Press, 1994.
59. Fernandez-Salguero P, Pineau T, Hilbert DM, McPhail T, Lee SS, Kimura S, Nebert DW, Rudikoff S, Ward JM, Gonzalez FJ. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 268:722-726, 1995.
60. Ladics GS, Kawabata TT, Munson AE, White KL Jr. Evaluation of murine splenic cell type metabolism of benzo[a]pyrene and functionality in vitro following repeated in vivo exposure to benzo[a]pyrene. Toxicol Appl Pharmacol 116:258-266, 1992.
61. Ashwell JD, King LB, Vacchio MS. Cross-talk between the T-cell antigen receptor and the glucocorticoid receptor regulates thymocyte development. Stem Cells 14:490-500, 1996.
62. Fehsel K, Kroncke KD, Meyer ML, Huber H, Wahn V, Kolb-Bachofen V. Nitric oxide induces apoptosis in mouse thymocytes. J Immunol 155:2858-2865, 1995.
63. Lerner A, Clayton LK, Mizoguchi E, Ghendler Y, Ewijk W, Koyasu S, Bhan AK, Reinherz EL. Cross-linking of T-cell receptors on double-positive thymocytes induces a cytokine-mediated stromal activation process linked to cell death. EMBO J 15:5876-5887, 1996.
64. 2 induces apoptosis in immature normal and malignant B lymphocytes. Immunol Immunopathol 63:221, 1992.
65. Zhi-Jun Y, Sriranganathan N, Vaught T, Arastu SK, Ahmed SA. A dye-based lymphocyte proliferation assay that permits multiple immunological analyses: mRNA, cytogenetic, apoptosis, and immunophenotyping studies. J Immunol Meth 210:25-39, 1997.
66. L. J Biol Chem 272:9868-9876, 1997.
67. Enan E, Matsumura F. Identification of c-Src as the integral component of the cytosolic Ah receptor complex, transducing the signal of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) through the protein phosphorylation pathway. Biochem Pharmacol 52:1599-1612, 1996.
68. Carver LA, Bradfield CA. Ligand-dependent interaction of the aryl hydrocarbon receptor with a novel immunophilin homolog in vivo. J Biol Chem 272:11452-11456, 1997.
69. Ma Q, Whitlock JP Jr. A novel cytoplasmic protein that interacts with the Ah receptor, contains tetratricopeptide repeat motifs, and augments the transcriptional response to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Biol Chem 272:8878-8884, 1997.
70. Lai Z-W, Pineau T, Esser C. Identification of dioxin-responsive elements (DREs) in the 5' regions of putative dioxin-inducible genes. Chem Biol Interact 100:97-112, 1996.
71. Baldwin AS Jr. The NF-κB and IκB proteins: New discoveries and insights. Annu Rev Immunol 14:649-681, 1996.
72. Baeuerle PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 12:141-179, 1994.
73. Heidel SM, Czuprynski CJ, Jefcoate CR. Bone marrow stromal cells constitutively express high levels of cytochrome P4501B1 that metabolize 7,12-dimethylbenz[a]anthracene. Mol Pharmacol 54:1000-1006, 1998.
74. Cui H, Ju S-T, Sherr DH. Functional expression of Fas (CD95) protein in autoimmune lpr mice. Cell Immunol 174:35-41, 1996.
75. Ju S-T, Panka DJ, Cui H, Ettinger R, El-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A. The molecular mechanisms of programmed cell death following T-cell activation requires Fas/FasL interactions. Nature 373:444, 1995.